Art

J-GLOBAL ID：200902113228105148   Reference number：02A0140465

Optimal Intensity of International Normalized Ratio in Warfarin Therapy for Secondary Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation.

非弁膜症性心房細動患者に対する心卒中の二次予防のためのワルファリン療法における国際的標準化比率の最適濃度

Author (3)： YASAKA M (National Cardiovascular Center, Suita) ,  MINEMATSU K (National Cardiovascular Center, Suita) ,  YAMAGUCHI T (National Cardiovascular Center, Suita)
Material： Internal Medicine  (Intern Med)
Volume： 40  Issue： 12  Page： 1183-1188  Publication year： Dec. 2001 
JST Material Number： Z0157B  ISSN： 0918-2918  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *auricular fibrillation ,...
Semi thesaurus term： 心塞栓性発作 ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=02A0140465&from=J-GLOBAL&jstjournalNo=Z0157B") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (1)： Warfarin

Reference (23)：

• PETERSEN, P. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989, 1, 175-179
• The Boston Area Anticoagulation Trial For Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990, 323, 1505-1511
• Stroke Prevention In Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study. Final Results. Circulation. 1991, 84, 527-539
• CONNOLLY, SJ. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. JACC. 1991, 18, 349-355
• EZEKOWITZ, MD. Warfarm in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1992, 327, 1406-1412

Terms in the title (9)： 非弁膜症性心房細動 ,  患者 ,  心 ,  二次予防 ,  ワルファリン ,  療法 ,  国際的標準 ,  比率 ,  最適濃度